OS Therapies, Inc. is seeking interim and final review data submissions from regulatory bodies while attending major global investment conferences.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
OS Therapies, Inc. is seeking interim and final review data submissions from regulatory bodies while attending major global investment conferences.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Both the FDA and the European Medicines Agency govern drug approval processes.
- The FDA requested additional clinical data from Unicycive Therapeutics.
- The FDA and European Medicines Agency are harmonizing regulatory review of drug applications.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.